TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro
TRIM33 overexpression can inhibit migration, invasion, and EMT in ccRCC; here, the potential molecular mechanisms are explored. (a and b) Wound healing assay. (c–e) Transwell assay, including migration and invasion experiments. (f–h) Western blot assay for TRIM33, E-cadherin, N-cadherin, vimentin, β-catenin, cyclin D1, c-myc, and β-actin. (i–k) Western blot assay after incubation with a Wnt signaling pathway agonist for β-catenin, cyclin D1, c-myc, and β-actin. ;;; ns represents no statistical significance.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.